Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

Lamivudine

134678-17-4C8H11N3O3S229.261 g/mol

A monothioacetal that consists of cytosine having a (2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl moiety attached at position 1. An inhibitor of HIV-1 reverse transcriptase, it is used as an antiviral in the treatment of AIDS and hepatitis B. — ChEBI

Safety references

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number134678-17-4ChEBI ↗
Molecular formulaC8H11N3O3SChEBI ↗
Molar mass229.261 g/molChEBI ↗
Monoisotopic mass229.05211 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:63577ChEBI ↗

Cross-source molecular data

PubChem
Molar mass229.26 g/molPubChem ↗
Exact mass229.05211239 DaPubChem ↗
Computed XLogP-0.9PubChem ↗
Topological polar surface area (Ų)113PubChem ↗
H-bond donors2PubChem ↗
H-bond acceptors4PubChem ↗
Rotatable bonds2PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
lamivudine
4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
JTEGQNOMFQHVDC-NKWVEPMBSA-N
Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1
InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1

Names & synonyms

4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-oneEpivir

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

antiviral agentantitubercular agentantiinfective agentantineoplastic agentantiviral drugprodrugallergenHIV-1 reverse transcriptase inhibitorEC 2.7.7.49 (RNA-directed DNA polymerase) inhibitorhepatoprotective agent

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00436184 mol

Uses 229.261 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 8 atoms
41.91%
O
Oxygen · 3 atoms
20.94%
N
Nitrogen · 3 atoms
18.33%
S
Sulfur · 1 atom
13.99%
H
Hydrogen · 11 atoms
4.84%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance. ↗The American journal of gastroenterology · 2002 Jul · PMID 12135009
On-line coupling of anion exchange and ion-pair chromatography for measurement of intracellular triphosphate metabolites of reverse transcriptase inhibitors. ↗Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2009 Nov 1 · PMID 19783232
WO9117159 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:63577

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 60825 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.